Related Experiment Video
Updated: Aug 6, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Mycobacterium tuberculosis signal transduction system required for persistent infections
1Department of Microbiology and Immunology, University of Michigan Medical School, 5641 Medical Science Building II, Ann Arbor, MI 48109-0620, USA.
Summary
A novel regulator, MprA, is crucial for Mycobacterium tuberculosis persistence. Targeting MprA could lead to new therapies against latent tuberculosis infections, a significant global health challenge.
Area of Science:
- Microbiology
- Infectious Diseases
- Molecular Biology
Background:
- Latent tuberculosis affects nearly 2 billion people globally.
- Current drugs fail to eliminate persistent Mycobacterium tuberculosis bacilli.
- Novel therapeutics targeting persistent infection are urgently needed.
Purpose of the Study:
- To identify regulatory determinants involved in Mycobacterium tuberculosis virulence.
- To investigate the role of a specific two-component response regulator in persistent infection.
Main Methods:
- Global analysis of regulatory determinants in M. tuberculosis.
- Inactivation of the Rv0981 (mprA) gene in M. tuberculosis H37Rv.
- In vivo growth assessment of M. tuberculosis in different organs and infection stages.
Main Results:
- Identified Rv0981 (mprA) as a key regulator for entering and maintaining persistent infection.
- MprA inactivation specifically impacted M. tuberculosis H37Rv growth in vivo.
- Demonstrated organ- and infection stage-specific effects of mprA.
Conclusions:
- Two-component systems, like MprA, are vital for M. tuberculosis adaptation during persistent infection.
- MprA is a potential therapeutic target for eliminating latent tuberculosis.
- Further research into MprA function may reveal new anti-tuberculosis strategies.
Related Concept Videos
01:30Bacterial Signaling
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:28Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...